Related Experiment Video
Updated: Jun 26, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
[Changes in the perception of benefits and risks of antidepressive pharmacotherapy]
1Klinik für Psychiatrie und Psychotherapie, Universität zu Köln, Kerpener Straße 62, 50937, Köln, Deutschland. cbaethge@uni-koeln.de.
Abstract:
Antidepressive pharmacotherapy has undergone various phases in its history. The euphoria of the early years on the relief of depressive symptoms was followed by a long period of clinical experience and intensive scientific work resulting in a more balanced perspective. Current debates circle around the actual effectiveness, especially with respect to long-term treatment, the prevention of suicide and the sequelae of discontinuation of an antidepressant. The evaluation of antidepressants as a group and often also the risk-benefit ratio of an individual treatment change over time. Antidepressants are typical for many forms of psychiatric treatment which, in a term from Hanfried Helmchen, are just as Janus-faced as psychiatry in a general sense is as a science and as a clinical discipline.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
The Placebo Effect
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy

